Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

Angelis Konstantinopoulos; Konstantinos Giannitsas; Spiros Raptis; Petros Perimenis

doi:10.33393/dti.2007.1310

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

Authors

Angelis Konstantinopoulos Department of Urology, University Hospital of Patras, Greece.
Konstantinos Giannitsas Department of Urology, University Hospital of Patras, Greece.
Spiros Raptis Department of Urology, University Hospital of Patras, Greece.
Petros Perimenis Department of Urology, University Hospital of Patras, Greece.

DOI:

https://doi.org/10.33393/dti.2007.1310

Keywords:

Endothelial dysfunction, erectile dysfunction, phosphodiesterase 5 inhibitors

Abstract

Endothelial dysfunction is a pathological entity that multiply affects the health status. Erectile dysfunction is being recognized as a condition that is strongly interrelated with endothelial dysfunction, being a vascular event itself. Oral pharmacotherapy for erectile dysfunction has provided us with a new armamentarium on this condition. Phosphodiesterase 5 inhibitors have been investigated and proved useful in clinical practice for erectile dysfunction but in addition to this, the results seem promising of a beneficial effect on endothelial dysfunction, as well.

Downloads

Download data is not yet available.

Downloads

Published

2007-01-01

How to Cite

Konstantinopoulos, A., Giannitsas, K., Raptis, S., & Perimenis, P. (2007). Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives. Drug Target Insights, 2(1). https://doi.org/10.33393/dti.2007.1310

Download Citation

Issue

Vol. 2 No. 1 (2007): January-December 2007

Section

Review

License

Authors contributing to Drug Target Insights agree to publish their articles under the Creative Common Attribution Non Commercial 4.0 (CC-BY-NC 4.0) license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.